Pasqal’s (PSQL) “Buy” Rating Reiterated at Canaccord Genuity Group

Canaccord Genuity Group restated their buy rating on shares of Pasqal (NASDAQ:PSQL – Free Report) in a research report report published on Monday morning,Benzinga reports. They currently have a $16.00 target price on the stock.

A number of other equities research analysts have also weighed in on PSQL. Zacks Research upgraded Pasqal to a “hold” rating in a research report on Thursday, September 24th. Roth Capital assumed coverage on Pasqal in a research report on Wednesday, September 9th. They issued a “buy” rating and a $20.00 target price for the company. Finally, UBS Group set a $16.00 price target on Pasqal in a research note on Tuesday, September 22nd. Three analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $16.80.

View Our Latest Stock Report on Pasqal

Pasqal Stock Up 3.6%

Shares of PSQL opened at $6.36 on Monday. Pasqal has a 52 week low of $6.07 and a 52 week high of $24.69.

About Pasqal

(Get Free Report)

Pasqal is a quantum computing company focused on developing neutral-atom quantum technology. The company designs quantum processors that use individually controlled atoms as qubits, along with the hardware, control systems and software needed to operate quantum computers.

Its offerings include access to quantum computing systems through cloud-based platforms, as well as software tools and services intended to help organizations develop and run quantum algorithms. Pasqal targets applications such as optimization, simulation, machine learning, drug discovery, energy and financial modeling.

Founded in France in 2019 by Georges-Olivier Reymond, Pasqal serves research institutions, corporations and public-sector organizations.

Further Reading

Receive News & Ratings for Pasqal Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pasqal and related companies with MarketBeat.com's FREE daily email newsletter.